Search images on Google Product Monograph
Active Ingredients:
- andusomeran, 0.1 MG/ML
DIN: 02541270
Dosage Form(s): DISPERSION
Route(s) of Administration: INTRAMUSCULAR
Description: 2.5 ML MULTIDOSE VIAL
Schedule: Schedule D
Company: MODERNA BIOPHARMA CANADA CORPORATION
ATC:
- J07 - VACCINES (ATC, WHO, Wiki)
- J07B - VIRAL VACCINES (ATC, WHO)
- J07BN - (ATC, WHO)
- J07BN01 - COVID-19, RNA-BASED VACCINE (WHO)